• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 (NKAIN2), Truncated

ACP08250

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08250 Target NameNKAIN2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5VXU1
Background Information
  • Uniprot Id

    Q5VXU1

  • Target Species

    Human

  • Target Name

    NKAIN2

  • Target Full Name

    Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2

  • Target Involvement

    A chromosomal aberration involving NKAIN2 is a cause of lymphoma. Deletion del(6)(q13q21) within NKAIN2 and involving SUSP1 generates the SUSP1-NKAIN2 product (PubMed:11979551).

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein.

  • Target Protein Families

    NKAIN family

  • Target Tissue Specificity

    Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined.

  • Target Synonyms

    NKAIN2; FAM77B; TCBA1; Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2; Na(+/K(+-transporting ATPase subunit beta-1-interacting protein 2; Protein FAM77B; T-cell lymphoma breakpoint-associated target protein 1

Inquire Recombinant Human Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 (NKAIN2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification